USDA scientists develop new DNA test that detects carriers of osteopetrosis in Red Angus; birth defect, which affects humans, cattle and other animals, causes abnormal brain and bone marrow cavity development

Andrew Rogers

Andrew Rogers

WASHINGTON , September 29, 2011 (press release) – A new test that detects a rare and deadly bone disorder in Red Angus is now available to cattle producers, thanks to U.S. Department of Agriculture (USDA) scientists.

Marble bone disease, also known as osteopetrosis, had not been seen in the United States since the 1960s until it resurfaced in Red Angus cattle three years ago. The birth defect, which affects humans, cattle and other animals, causes abnormal brain and bone marrow cavity development, leading to overly dense, brittle bones. Calves with the mutation usually are stillborn or die soon after birth.

To stop the disease in cattle, scientists at the Agricultural Research Service (ARS) Roman L. Hruska U.S. Meat Animal Research Center (USMARC) in Clay Center, Neb., and the Henry A. Wallace Beltsville Agricultural Research Center (BARC) in Beltsville, Md. collaborated with several university and Red Angus Association of America partners to identify the gene mutation responsible for the disorder. They then developed a DNA diagnostic test that identifies osteopetrosis carriers.

ARS is USDA's chief intramural scientific research agency, and this research supports USDA's priority of promoting international food security.

Chemist Tim Smith and geneticist Tara McDaneld in the USMARC Genetics and Breeding Research Unit, BARC geneticist Tad Sonstegard and University of Illinois scientists compared DNA from affected Red Angus calves and their carrier parents to unaffected animals. A search of the entire genomes of all the calves for common and uncommon chromosomal segments revealed an abnormality.

In osteopetrosis-affected calves, some of the genetic material of SLC4A2, a gene located on a segment of chromosome 4, had been deleted. The discovery of the deletion was a first for cattle, according to McDaneld. SLC4A2 is necessary for proper osteoclast maintenance and function. Osteoclasts are cells that break down old bone during bone development and remodeling.

Scientists were able to develop a polymerase chain reaction test in less than a year, according to Smith. The test is being used to help manage osteopetrosis and identify possible carriers.

Findings from this research were published in Biomed Central Genomics.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

Share:

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.